You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Medtronic
Harvard Business School
Mallinckrodt
Colorcon

Last Updated: September 27, 2023

Investigational Drug Information for Nitrendipine


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Nitrendipine?

Nitrendipine is an investigational drug.

There have been 9 clinical trials for Nitrendipine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Hypertension, Systolic Murmurs, and Neoplasm Metastasis. The leading clinical trial sponsors are Merck KGaA, Merck KGaA, Darmstadt, Germany, and Katholieke Universiteit Leuven.

Recent Clinical Trials for Nitrendipine
TitleSponsorPhase
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.Shanghai Jiao Tong University School of MedicinePhase 4
Coronavirus (COVID-19) ACEi/ARB InvestigationNational University of Ireland, Galway, IrelandPhase 4
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid TumorAlphacait, LLCPhase 2

See all Nitrendipine clinical trials

Clinical Trial Summary for Nitrendipine

Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine

See all Nitrendipine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Medtronic
Harvard Business School
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.